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Background: Numerous clinical studies have reported that ingestion of chocolate has reduced risk of metabolic
syndrome. In order to elucidate the mechanism, we evaluated the influence of flavan-3-ols derived from cocoa
powder on energy metabolism in mice using an indirect calorimetric method.
Method: The mice were divided into two groups, and administered either distilled water or 50 mg/kg of flavan-3-ol
fraction for 2 weeks. At the end of the experimental period, animals were sacrificed after blood pressure and the
mean respiratory exchange ratio (RER) over 24 hours were measured.
Results: The mean respiratory exchange ratio (RER) over 24 hours was reduced significantly in the flavan-3-ols
group. The mean blood pressure was significantly decreased in flavan-3-ols treatment group compared with control
group. The protein level of carnitine palmitoyltransferase 2 (CPT2) was increased significantly by flavan-3-ols in
skeletal muscle, but not in liver. Uncoupling protein (UCP) 1 was increased significantly in brown adipose tissue by
flavan-3-ols. The mitochondria copy number in gastrocnemius and soleus muscles and brown adipose tissue were
increased significantly by administration of flavan-3-ol fraction.
Conclusion: These results suggest that flavan-3-ols enhances lipolysis and promotes mitochondrial biogenesis. We
conclude that improvement of metabolic syndrome risk factors following ingestion of chocolate may be induced,
in part, by the mitochondrial biogenesis-promoting effect of flavan-3-ols.
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Flavan-3-ols, a group of polyphenolic substances, are dis-
tributed in a number of plant foods such as cocoa beans,
red wine, and apples. Of these foods, chocolate is known
to be rich in flavan-3-ols, including the flavan 3-ol mono-
mers, (+)-catechin and (−)-epicatechin, and oligomers,
B-type procyanidins that are linked by C4-C8 bonds [1-3].
Recent meta-analyses suggested that ingestion of choc-
olate reduced the risk of cardiovascular diseases [4,5].
These reports showed that chocolate consumption was
associated with a substantial reduction in the risk of car-
diometabolic disorders such as coronary heart disease
and stroke. In addition, numerous randomized, con-
trolled trials have confirmed that chocolate, especially* Correspondence: nao-osa@sic.shibaura-it.ac.jp
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improves risk factors for the metabolic syndrome such
as hypertension [6,7], vascular endothelial dysfunction
[8,9], dyslipidemia [10,11], and glucose intolerance [12,13].
Several meta-analyses conducted after these clinical trials
confirmed that dark chocolate rich in flavan-3-ols reduced
the risk of cardiovascular disease by improving these risk
factors [14-19].
On the other hand, it has been reported that the ab-
sorption rate of flavan-3-ol monomers was only about
10 - 20%, with these compounds present in blood mainly
as metabolites such as conjugated forms with glucuronide
and/or sulfate. In contrast, unchanged forms were nearly
absent after ingestion of flavan-3-ols [20,21]. Flavan 3-ol
oligomers were also shown to be poorly absorbed via the
gastrointestinal tract and present in very low concentra-
tions in the blood [22,23]. The mechanism of the multipleral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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metabolic syndrome has therefore remained unclear.
In order to elucidate this mechanism, we evaluated the
effect of repeated supplementation of flavan-3-ols on en-
ergy metabolism using an indirect calorimetric method.
We also compared the changes of uncoupling protein,
lipid metabolizing enzymes and mitochondria copy num-




The flavan 3-ol fraction was provided by Meiji Co., Ltd
(Tokyo, Japan). The flavan- 3-ol fraction was prepared
from cocoa powder by the method described in a previous
report [24]. Briefly, cocoa powder was defatted with
n-hexane, and then the residue was extracted with acet-
one. The n-butanol dissolved fraction of the extract was
applied to a Diaion HP2MG column (Mitsubishi Kasei
Co. Ltd., Tokyo, Japan). The fraction eluted with 80%
ethanol was collected, freeze dried, and then used. The
composition of this fraction was shown in Table 1. Total
polyphenol was as determined by the Prussian blue
method [24]. Catechins. procyanidins and xanthine deriva-
tives were analyzed by an HPLC method [25]. Briefly, the
analysis was carried out by linear gradient with 0.1% triful-
oroacetic acid in CH3CN and 0.1% trifuloroacetic acid in
H2O using Deverosil ODS HG-5 column (Nomura Chem-
ical CO. Ltd., Aichi, Japan) and detected at 280 nm.
Animals and diets
The study was approved by the Animal Care and Use
Committee of Shibaura Institute of Technology. All the
animals received humane care under the guidelines of
this institution.
Seven weeks old male C57BL/J mice were obtained












1)Total polyphenols was determined Prussian blue method [24].
2)Catechins, procyanidins and xanthine derivatives were determined by HPLC
method [25].a room at a regulated temperature of 23–25°C and con-
trolled lighting (12-h light and dark cycles). The basal
diet was MF obtained from the Oriental Yeast, Co. Ltd.,
Tokyo, Japan.
Experimental procedures
Twelve animals were fed the basal diet for 4 days and
then allocated to two groups. Mice in the control group
received oral intake of distilled water, while animals in
the flavan-3-ols group were administrated flavan-3-ols
(50 mg/kg b.w./day, p.o.) in distilled water for 2 weeks.
At the end of this supplementation period, each mouse
was placed into an open-circuit metabolic chamber for a
24-hour fasting period, and then VO2 and VCO2 were
determined by indirect calorimetry using a small animal
metabolic measurement system (MK-5000RQ Muroma-
chi Kikai Co. Ltd, Tokyo, Japan). The system monitored
VO2 and VCO2 at 3-min intervals and calculated the re-
spiratory exchange ratio (RER). RER was calculated by
following formula; RER =VCO2/VO2. The measurements
of VO2 and VCO2 were converted to resting energy
expenditure (REE) (kcal/day) using the Weir equation by
following formula; REE = (3.941VO2 + 1.11VCO2)*1.44*60
(min)*24(h). To measure spontaneous motoractivity while
sedentary, the mouse was placed individually in a chamber
equipped with an infrared-ray passive sensor system
(MMP10, Muromachi Kikai). Measurements were per-
formed during dark (from 19:00 to 7:00) and light (from
7:00 to 16:30) periods under fasting conditions. The blood
pressure of each animal was measured by a tail-cuff
method (MK-2000ST, Muromachi Kikai Tokyo Japan) be-
fore and at the end of the supplementation period. After
all the measurements had been completed, the mouse was
anesthetized and its blood sample was collected from the
abdominal vein using heparinized syringes. Tissues sam-
ples were then collected by dissection and snap frozen in
liquid nitrogen and stored at −80°C until analysis.
Plasma biochemical assays
Plasma glucose and free fatty acid levels were determined
by commercially available kits (Wako glucose CIItest and
Wako NEFA C-test; Wako Chemicals, Tokyo, Japan).
Western blotting analysis
Each tissue was homogenized in micro tubes with lysis
buffer (CelLytic™ MT cell lysis Reagent: SIGMA-Aldrich,
Japan) containing protease inhibitor (SIGMA-Aldrich
Japan) and 0.2% SDS. The protein concentration was
measured by the Bradford method. A 50 μg aliquot of
protein was separated by SDS-PAGE using 4-12% Bis-Tris
gel and then transferred onto polyvinylidene difluoride
membranes (Life Technology, USA). The membranes were
blocked with membrane blocking reagent (GE Healthcare,
Buckinghamshire, UK) for 1 hour, and then incubated for
Table 2 Body and tissue weight, plasma biochemicals and
mean blood pressure of mice administrated saline or
50 mg/kg flavan-3-ols for 2 weeks
Control Flavan-3-ols
(n=6) (n=6)
Body weight, g 22.5 ± 0.76 23.0 ± 0.26
Liver, g 0.85 ± 0.03 0.85 ± 0.04
Gastrocnemius, g 0.31 ± 0.03 0.33 ± 0.02
Soleus, g 0.02 ± 0.003 0.02 ± 0.003
Brown adipose tissue, g 0.05 ± 0.01 0.07 ± 0.07
Epidermal fat, g 0.16 ± 0.04 0.21 ± 0.02
Posterior abdominal fat, g 0.06 ± 0.01 0.06 ± 0.01
Plasma free fatty acid, mg/dl 0.67 ± 0.13 0.83 ± 0.14
Plasma glucose, mg/dl 194 ± 38.8 143 ± 33.4*
Mean blood pressure, mmHg 108 ± 5.2 96.5 ± 6.0*
Each value represents mean and SD.
Significantly difference from control; *p<0.05.
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either UCP1 (1:2500; ab1983, Abcam, Cambridge, UK),
UCP2 (1:2500; ab97931, Abcam), UCP3 (1:2000; ab3477,
Abcam), CPT-2 (1:500; sc-20671, Santa Cruz, Santa Cruz,
USA), MCAD (1:1000; sc-98926, Santa Cruz) or α-tubulin
(1:2000; ab4074, Abcam). After the primary antibody reac-
tion, the membranes were incubated for 1 hour with the
appropriate horseradish peroxidase-conjugated secondary
antibody (1:100000). Immunoreactivity was detected by
chemiluminescence using the ECL select™ Western
Blotting Reagent (GE Healthcare, Buckinghamshire, UK).
Fluorescence band images were analyzed using Just TLC
(Liponics, Tokyo, Japan) analysis software. Each value was
normalized relative to α-tubulin.
Measurement of mitochondrial copy number
To measure mitochondrial DNA (mtDNA) copy num-
ber, total DNA was isolated from each organ using the
QIAamp® DNA mini kit (QIAGEN Ltd., Tokyo, Japan),
and 50 ng of total DNA used for real-time PCR. PCR
was performed using a Step One real-time PCR system
(Applied Biosystems Japan Ltd., Tokyo, Japan). The pri-
mer and probe sets used were TaqMan® Gene Expression
Assay (Applied Biosystems Foster City, USA; ACTB,
Mm00607939_s1; CYTB, Mm04225274; ND1, Mm0422
5271_g1). The buffer used in the system was TaqMan®
Gene Expression Master Mix (Applied Biosystems). The
PCR cycling conditions were 50°C for 2 min, 95°C for
10 min, followed by 40 cycles of 95°C for 15 s, and 60°C
for 1 min. Data analysis was based on measurement of the
cycle threshold (CT), which represents the PCR cycle
count when fluorescence measurement reaches a target
value. mtDNA copy number was expressed relative to nu-
clear DNA following amplification of the mitochondrial
gene region (cytochrome b and NADH dehydrogenase 1
vs. the nuclear endogenous control region, β-actin).
Data analysis and statistical methods
The data were expressed as the mean and standard devi-
ation. The effect of each treatment, if any, was then com-
pared to the control using a two-sample t-test. P values <
0.05 were considered statistically significant.
Results
Body weight, tissue weight, plasma biochemical
parameters, and blood pressure
Table 2 shows the body weight, tissue weight, and blood
pressure of the animals at the end of the supplementa-
tion period. There was no significant difference in body
or tissue weight between the two test groups. The ad-
ministration of flavan-3-ols caused a small but statisti-
cally insignificant increase in the levels of plasma free
fatty acids and a significant decrease in plasma glucose
levels compared with the control group (p < 0.05). Meanblood pressure was reduced significantly in the flavan-
3-ols group compared with the control group (p < 0.05).
Resting energy expenditure and activity counts
Figure 1 shows the RER (a) and activity counts (b) of the
animals over 24 hours at the end of the experimental
period. Mean RER (c) and total activity count (d) over
24 hours that included a light cycle from 6:00 to 18:00
and dark cycle from 18:00–6:00 are also shown. As shown
in Figure 1a, RER was marginally lower in the flavan-3-ols
group compared with the control group throughout the
measurement period, whereas there was no difference in
motor-activity between the two groups (Figure 1b). There
was a significant reduction in mean RER associated with
flavan-3-ols treatment compared with the control group
for the total duration of the experiment (Figure 1c). No
difference was observed in total locomotor activity be-
tween the two groups (Figure 1d). There was not a signifi-
cantly difference in REE between experimental groups.
Western blotting analyses of β-oxidation-related enzymes
in tissues
As shown in Figure 2a, administration of flavan-3-ols
caused a small but statistically insignificant increase MCAD
protein level in the gastrocnemius and soleus muscles and
liver. In contrast, CPT-2 was increased significantly in the
gastrocnemius and soleus muscles following treatment with
flavan-3-ols, but remained unchanged in the liver.
Western blotting analyses f uncoupling proteins in tissues
Uncoupling protein 1 (UCP-1) in brown adipose tissue
was elevated significantly in the flavan-3-ols group com-
pared with the control group (Figure 3a). As shown in























































































Figure 1 Alterations of repeated ingestion of flavan 3-ols on whole animal energy metabolism by indirect calorimetric method. Resting
respiratory exchange ratio (RER) (a) and locomotor activity (b) were measured for 24 h after 2 weeks repeated ingestion of flavan-3-ols. Open
circle indicated control group, dark square indicated flavan-3-ols treatement group. Average of RER (c) and total activity count (d) were calculated
from the value during experimental period, light cycle period or dark cycle period. RER was calculated based on expired CO2 and O2 consumed
(RER = VCO2/VO2). Each cage was measured for 1 min every 3 min. Gray background shading or lack thereof indicates the dark and light cycles.









































































Figure 2 Influence of repeated ingestion of flavan-3-ols on the enzymes in β-oxidation. Medium-chain acyl-CoA dehydrogenase (MCAD)
(a) and carnitine palmitoyltransferase 2 (CPT-2) (b) in gastrocnemius, soleus and liver were measured for 24 h after 2 weeks repeated ingestion
of flavan-3-ols by western blotting analysis as described in Materials and Methods. The protein level was expressed the ratio of enzymes to
α-tubulin. Values are means and SD of 6 mice. *p < 0.05 vs control group (t test).













































































































Figure 3 Effect of repeated ingestion of flavan-3-ols on the uncoupling proteins. Uncoupling protein 1 (UCP-1) in brown adipose tissue
(a), uncoupleing protein 2 (UCP-2) in liver (b) and white adipose tissue and uncoupleing protein 3 (UCP-3) (c) in gastrocnemius and soleus were
measured for 24 h after 2 weeks repeated ingestion of flavan-3-ols by western blotting analysis as described in Materials and Methods. The
protein level was expressed the ratio of enzymes to α-tubulin. Values are means and SD of 6 mice. *p < 0.05 vs control group (t test).
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between the two groups. Uncoupling protein 3 (UCP-3)
was increased slightly in the gastrocnemius and soleus
muscles following treatment with flavan-3-ols, although































Figure 4 Mitochondrial promoting activity of repeated ingestion of fl
gastrocnemius, soleus, brown adipose tissue and white adipose tissue were
by PCR described in Materials and Methods. mtDNA copy number was exp
mitochondrial gene region (cytochrome b and NADH dehydrogenase 1 vs.
as the ratio flavan-3-ols to control. Graph shows means and SD of 6 mice.Mitochondria copy number in tissues
As shown in Figure 4, there was a significant increase in
mitochondria copy number in the gastrocnemius and so-
leus muscles and brown adipose tissue in the flavan-3-ols










avan-3-ols. Mitochondrial DNA (mtDNA) and nuclear DNA in
measured for 24 h after 2 weeks repeated ingestion of flavan-3-ols
ressed relative to nuclear DNA following amplification of the
the nuclear endogenous control region, β-actin). Values are expressed
*p < 0.05 vs control group (t test).
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liver and white adipose tissue between the two experi-
mental groups.
Discussion
The possibility that ingestion of chocolate can reduce
the risk of cardiovascular disease was reported in recent
meta-analyses [4,5]. Several other meta-analyses have
also demonstrated that cocoa products rich in flavan-
3-ols have multiple effects on cardiovascular risk factors
such as hypertension, dyslipidemia, and glucose intoler-
ance. However, the effective component in chocolate
and the mechanism of these multiple effects remains
unclear. In the present study, we found that mean rest-
ing energy expenditure was reduced significantly by
xanthine derivatives free flavan-3-ol fraction derived
from cocoa powder (Figure 1c), and that this decrease
was not affected by locomotor activity (Figure 1d). We
also showed mean blood pressure and fasting blood
glucose level were significantly lower in mice treated
with flavan-3-ols compared with controls (Table 2). Our
series of experiments on flavan-3-ols treatment showed
a slight induction of MCAD in skeletal muscle a rate-
controlling enzyme in β-oxidation, and a significant in-
crease in gastrocnemius and CPT-2 in soleus muscles, a
mitochondrial enzyme. In contrast, no increase in CPT-
2 was observed in the liver (Figure 2b). UCP-1 in brown
adipose tissue was also induced significantly by flavan-
3-ols treatment, whereas UCP-2 in liver and white
adipose tissue and UCP-3 in skeletal muscle remained
largely unchanged (Figure 3). In addition, we confirmed
that biogenesis of mitochondria was increased signifi-
cantly in skeletal muscle, such as the soleus and gastro-
cnemius muscles (Figure 4). In contrast, no significant
change was observed in mitochondria copy number in
liver and white adipose tissue. Skeletal muscle is known
to contribute largely to whole body energy expenditure
through its mitochondrial oxidative phosphorylation and
thermogenesis [26]. The promotion activity of flavan-3-ols
on the skeletal muscle mitochondrial biosynthesis sug-
gested the possibility of improvement of metabolic syn-
drome by additional energy expenditure.
On the other hand, several systematic reviews have con-
firmed that consumption of dark chocolate rich in flavan-
3-ols decreases blood pressure [14-19]. The current study
confirmed the reduction in blood pressure. The mechan-
ism of this hypotensive effect has been attributed to orally-
administrated flavan-3-ols being distributed in vascular
endothelial cells, resulting in direct stimulation of endo-
thelium nitric oxide synthetase [27]. As described above,
flavan-3-ols other than monomers are poorly absorbed,
and are unlikely to have a direct influence on endothe-
lial cells. Further studies focusing on the circulation are
therefore needed to elucidate the hypotensive mechanismof flavan-3-ols. Nevertheless, it was confirmed that the ef-
fective component in chocolate that improved metabolic
syndrome risk factors was flavan-3-ols according to the re-
sults of the present study.
Numerous authors have demonstrated an increase in
lipolysis following intake of polyphenols. For instance,
catechins in green tea have been reported to enhance en-
ergy expenditure by inhibiting catechol O-methyl transfer-
ase [28]. These results indicate green tea does not enhance
energy expenditure or lipolysis by itself. Catechins in green
tea showed a significant effect on energy metabolism at a
high level of blood catecholamines, such as after either
caffeine ingestion or during exercise [29-33]. Chocolate
also contains caffeine found in green tea. An intervention
trial of caffeine demonstrated that they may contribute to
alterations in energy metabolism [34]. There was limited
information about the interaction between theobromine
and polyphenols in cocoa. Etherton et al. reported that the
xanthine derivatives unlikely to have significant impact on
the reducing activity of LDL oxidative susceptibility of
cocoa in randomized control study using theobromine
capsule [35]. As the present study investigated xanthin
drivatives-free fraction of flavan-3-ol derived from cocoa
powder, the results suggest that flavan-3-ols enhance
fat oxidation independent of prolonged increases in
blood catecholamines levels induced by xanthine deriv-
atives. Further evidence for this ability of polyphenols
to directly modify energy metabolism was provided in a
recent study by Goto et al., which showed repeated
ingestion of tiliroside, a glycosidic flavonoid, reduced
RER and elevated AMP-activated protein kinase in both
the liver and skeletal muscle [36]. It has also been shown
in mice that RER is reduced significantly by ingestion of
coffee polyphenols [37].
Several reports have suggested that polyphenols inhibit
glucose and fat absorption and/or digestion by inhibiting
gastrointestinal enzymes [38,39]. Similarly, flavan-3-ols
derived from cocoa powder have been demonstrated to
inhibit dietary fat absorption [40,41]. In these studies, it
was suggested that at least 300 to 800 mg/kg flavan-3-ol
fraction was needed to inhibition of glucose or fat ab-
sorption and/or digestion. According to these previous
results, it was unlikely suggested that the administration
of 50 mg/kg flavan-3-ol fraction had a significant influ-
ence on digestion and absorption of carbohydrate or fat.
We observed an elevation in mitochondria copy number
in skeletal muscle following supplementation of flavan-
3-ols. A similar increase in mitochondrial biogenesis in
skeletal muscle was also reported in patients with type 2
diabetes or heart failure following ingestion of cocoa [42].
According to the previous reports, peroxisome proliferator-
activated receptor γ coactivator α (PGC-1α) is recognized
as a master regulator of mitochondrial biogenesis [43-45]
by activating respiratory chain and fatty acid oxidation
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mitochondrial respiratory capacity. It has been shown
that PGC-1α exerts these effects through direct or coac-
tivation with peroxisome proliferator-activated recep-
tors (PPARs), estrogen-related receptors (ERRs), and
nuclear respiratory factors (NRFs). Transcription factors
such as myocyte enhancer factor 2 (MEF2), forkhead
box class-O (FoxO1), activating transcription factor 2
(ATF2), and cAMP response element-binding protein
(CREB) enhance PGC-1α transcription during physio-
logical stress such as exercise, cold, fasting, and increased
cytokine production [46]. For UCP gene expression, PGC-
1α interacts with different nuclear hormone receptors de-
pending on the stimuli, with PPARγ being one of the key
transcription factors. For activation of fatty acid oxidation
enzymes, PGC-1α uses different transcription factors such
as PPARα and estrogen-related receptors (ERRs), that are
expressed at high levels in brown adiposities [47]. In the
present study, we observed an elevation in mitochondrial
copy number, and induction of UCPs and β-oxidation
enzymes in several tissues. These results suggested that in-
gestion of flavan-3-ols augmented PGC-1α transcription.
Conclusions
This study suggested repeated ingestion of flavan-3-ols
derived from cocoa was enhanced lipolysis and promoted
mitochondrial biogenesis. These effects may contribute to
the improvement in metabolic syndrome risk factors dem-
onstrated in several meta-analyses.
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